
Last month’s performance of 1.23% for Editas Medicine Inc (EDIT) is certainly impressive
On Tuesday, Editas Medicine Inc (NASDAQ: EDIT) was -3.89% drop from the session before settling in for the closing price of $2.57. A 52-week range
On Tuesday, Editas Medicine Inc (NASDAQ: EDIT) was -3.89% drop from the session before settling in for the closing price of $2.57. A 52-week range
Editas Medicine Inc (NASDAQ: EDIT) on Monday, plunged -9.90% from the previous trading day, before settling in for the closing price of $3.03. Within the
As on Wednesday, Editas Medicine Inc (NASDAQ: EDIT) got off with the flyer as it spiked 34.50% to $3.08, before settling in for the price
Editas Medicine Inc (NASDAQ: EDIT) kicked off on Friday, down -11.24% from the previous trading day, before settling in for the closing price of $2.49.
On Monday, Editas Medicine Inc (NASDAQ: EDIT) was 4.92% up from the session before settling in for the closing price of $2.44. A 52-week range
Editas Medicine Inc (NASDAQ: EDIT) flaunted slowness of -0.40% at $2.51, as the Stock market unbolted on Thursday, before settling in for the price of
On Monday, Editas Medicine Inc (NASDAQ: EDIT) was -6.03% drop from the session before settling in for the closing price of $3.15. A 52-week range
Witnessing the stock’s movement on the chart, on Thursday, Editas Medicine Inc (NASDAQ: EDIT) had a quiet start as it plunged -5.78% to $3.26, before
Editas Medicine Inc (NASDAQ: EDIT) kicked off on Monday, up 14.13% from the previous trading day, before settling in for the closing price of $2.76.
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.